Innovative Systems Enhance Drug Delivery and Strengthen Market Leadership

Laser Photonics Corporation (NASDAQ: LASE) (“LPC”), a leading global developer of industrial laser systems for cleaning and other material processing applications, and its subsidiary, Control Micro Systems, Inc. (“CMS Laser”), highlight their offerings in tablet laser drilling technology, reinforcing their status as a trusted partner in the pharmaceutical industry.

The TD-140, TD-70, TD-10, and TD-R&D systems address a wide range of pharmaceutical needs, from high-volume tablet drilling and marking to research and development. Designed and built at CMS Laser’s advanced laser lab and machine shop in Winter Park, Florida, these systems create precise time-release profiles and ensure robust quality control, empowering drug manufacturers to meet the demands of a dynamic market.

John Armstrong, the Executive Vice President of LPC, said: “CMS Laser holds a significant market position in the pharmaceutical industry, offering superior technologies for high-volume pill production. This lineup of tablet drilling, marking, and R&D systems is designed specifically to solve industry-specific challenges, enabling pharmaceutical leaders to deliver complex medications with confidence.”

CMS Laser’s technology delivers key advantages:

• Enhanced Drug Delivery: Precise laser drilling supports controlled API time-release, improving patient outcomes.
• Anti-Counterfeit Protection: Unique tablet markings safeguard brands and patients.
• FDA Compliance: Systems adhere to CFR-21 Part 11 standards.
• U.S.-Based Manufacturing: CMS Laser provides solutions with components sourced in accordance with TAA and the Buy American Act.
• Post-Sale Support: CMS Laser is easy to reach for support, training, and installation services.
• Operational Efficiency: Laser-based solutions optimize production.

With a legacy of serving industry giants and a strong base of repeat clients, CMS Laser, a Laser Photonics company, continues to set standards in pharmaceutical manufacturing. This aligns perfectly with LPC’s broader diversification strategy, aimed at enhancing shareholder value and building resilience in dynamic markets.

About Laser Photonics Corporation

Laser Photonics is a vertically integrated manufacturer and R&D Center of Excellence for industrial laser technologies and systems. Laser Photonics seeks to disrupt the $46 billion, centuries-old sand and abrasives blasting markets, focusing on surface cleaning, rust removal, corrosion control, de-painting and other laser-based industrial applications. Laser Photonics’ new generation of leading-edge laser blasting technologies and equipment also addresses the numerous health, safety, environmental and regulatory issues associated with old methods. As a result, Laser Photonics quickly gained a reputation as an industry leader in industrial laser systems with a brand that stands for quality, technology and product innovation. Currently, world-renowned and Fortune 1000 manufacturers in the aviation, automotive, defense, energy, maritime, nuclear and space industries are using Laser Photonics’ “unique-to-industry” systems. For more information, visit https://www.laserphotonics.com.

About CMS Laser

Control Micro Systems (CMS Laser), is a 40-year U.S. pioneer in software controls development for laser machines. Today, the company produces turnkey laser material processing systems for marking, cutting, drilling, welding, cleaning and more. Its cutting-edge laser systems are expertly engineered for high-precision applications in a wide range of industries and tailored to each client’s unique manufacturing needs. CMS Laser specializes in developing laser systems for a wide range of industries. It also counts several top 20 global life sciences companies among their customers. For more information, visit Control Micro Systems, Inc., a Laser Photonics company.

Cautionary Note Concerning Forward-Looking Statements

This press release contains “forward-looking statements” (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended), including statements regarding the Company’s plans, prospects, potential results and use of proceeds. These statements are based on current expectations as of the date of this press release and involve a number of risks and uncertainties, which may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. These risks include, without limitation, those described under the caption “Risk Factors” in the Registration Statement. Any reader of this press release is cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release except as required by applicable laws or regulations.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250514938775/en/

"CMS Laser offers superior technologies for high-volume pill production. Their tablet drilling, marking, and R&D systems are designed to solve industry-specific challenges, enabling pharmaceutical leaders to deliver complex medications with confidence."